Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Niels van de Donk, MD, PhD, from VU University Medical Center, Amsterdam, The Netherlands, explains how we can maintain CAR T-cell therapy responses in the myeloma space. This interview was speaking at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
We use cookies to provide the best experience on our website. We also use third party cookies to collect analytical data and better improve our marketing strategies. If you continue to use this site you are consenting to the use of these cookies. For more information view our Cookie Policy.